Daniel L.  Forman

Daniel Forman is a partner in Proskauer’s Capital Markets Group. His practice focuses on securities offerings and related transactions, and he regularly represents issuers, sponsors, investors and underwriters in securities transactions including initial public offerings, secondary equity offerings, debt offerings, convertible note offerings, tender offers and consent solicitations, debt restructurings and private placements. He also counsels public companies on general corporate representation, SEC compliance, disclosure matters, mergers and acquisitions and complex securities law issues. Daniel has significant experience advising on transactions for companies in the life sciences, technology, consumer/retail, industrial, financial institutions and real estate sectors.

Read More >

Select representations include:

Initial public offerings, debt offerings and follow-on offerings for:

  • Eloxx Pharmaceuticals, Solid Biosciences, Leisure Acquisition Corp., Fifth Street Asset Management, Suburban Propane Partners, Installed Building Products, and Annie’s.
  • Healthcare Trust Inc., New York City REIT, Inc., Preferred Apartment Communities, Global Net Lease, Inc. and American Finance Trust, Inc

Numerous bulge-bracket and boutique investments banks in initial public offerings, debt offerings and follow-on offerings for:

  • Sangamo Therapeutics, Vanda Pharmaceuticals, Kura Oncology, Intra-Cellular Therapies, Ariad Pharmaceuticals, Casella Waste, PulteGroup, Five Point Holdings, WCI Communities and Alcentra Capital Corporation.

Daniel also regularly represents and advises issuers and underwriters on a variety of alternative offering types, including PIPEs, Confidentially Marketed Public Offerings (CMPOs), Registered Direct Offerings (RDOs), At-the-Market Offerings (ATMs), and special structures such as Special Purpose Acquisition Companies (SPACs) and Business Development Companies (BDCs).

Daniel also has experience with non-traditional equity transactions, including debt-like preferred equity as third party financing, equity kickers and co-investments for private credit investors and debt for equity swaps.

He is a co-author of Proskauer’s IPO Study and SPAC IPO Study and has contributed articles to, among others, Lexis Practice Advisor (Top 10 Practice Tips: Emerging Growth Companies) and Global Legal Insights Initial Public Offerings 2018 Second Edition (Trends Shaping an Evolving IPO Market).

Daniel is a member of the Securities Regulation Committee of the New York City Bar Association and has been included in The Legal 500 United States: Capital Markets: Equity Offerings: Advice to Issuers (2018).

Daniel is an adjunct professor of law at the Benjamin N. Cardozo School of Law, teaching an upper-level Contract Drafting course and assisting with professional skills development programs. He is also involved in a number of pro bono matters at the firm relating to legal support for small business entrepreneurs voter rights protection and refugee assistance and is an active supporter of the Red Hook Initiative in Brooklyn.